AstraZeneca CEO Heralds New Era of Collaboration
The Cambridge Independent website reported that AstraZeneca CEO Pascal Soriot announced that the company’s advanced drug discovery robot, NiCoLA-B, will be housed in the biopharmaceutical company’s new £500million global research and development center, heralding a new era of openness and collaboration between life science researchers. “Our
Comments Off on AstraZeneca CEO Heralds New Era of Collaboration • Read this story »